Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer

被引：0
|
作者：
Xinguang Wang
Yingjian He
Tianfeng Wang
Yuntao Xie
Jinfeng Li
Tao Ouyang
Zhaoqing Fan
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Center
来源：
Supportive Care in Cancer | 2019年 / 27卷
关键词：
Pegfilgrastim; Febrile neutropenia; Dose-dense chemotherapy; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3019 / 3025
页数：6
相关论文
共 50 条
  • [1] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Wang, Xinguang
    He, Yingjian
    Wang, Tianfeng
    Xie, Yuntao
    Li, Jinfeng
    Ouyang, Tao
    Fan, Zhaoqing
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 3019 - 3025
  • [2] Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Naruse, Saki
    Isono, Yuka
    Maeda, Yuka
    Sato, Ayana
    Yamada, Miki
    Ikeda, Tatsuhiko
    Sasajima, Yuko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (12) : 1119 - 1124
  • [3] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.
    Cramer, EM
    Moers, C
    Zarghooni, V
    Mallmann, P
    Warm, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 82S - 82S
  • [4] Safety and tolerance of dose-dense Epirubicin and Cyclophosphamide (EC) with Pegfilgrastim for Japanese patients with early breast cancer
    Watanabe, K.
    Yamamoto, M.
    Sato, M.
    Tomioka, N.
    Takahashi, M.
    BREAST, 2017, 32 : S27 - S28
  • [5] Efficacy of a half-dose pegfilgrastim for dose-dense doxorubicin and cyclophosphamide in Japanese breast cancer patients
    Mizuno, Y.
    Fuchikami, H.
    Takeda, N.
    Inoue, Y.
    Seto, H.
    Sato, K.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S97 - S98
  • [6] Dose-dense neoadjuvant chemotherapy in breast cancer.
    Catane, R
    Kaufman, B
    Zach, L
    Wolf, I
    Gluck, I
    Modiano, T
    Barsuk, D
    Shabtai, M
    Papa, M
    Paluch-Shimon, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 79S - 79S
  • [7] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer
    Cramer, EM
    Moers, C
    Zarghooni, V
    Bosse, K
    Mallmann, P
    Warm, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S231 - S231
  • [8] Efficacy of reduced dose of pegfilgrastim in Japanese breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide therapy
    Mizuno, Yoshio
    Fuchikami, Hiromi
    Takeda, Naoko
    Iwai, Masaru
    Sato, Kazuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (01) : 12 - 17
  • [9] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer
    Grassadonia, Antonino
    Cianchetti, Ettore
    Ficorella, Corrado
    Angelucci, Domenico
    Grossi, Simona
    Ricevuto, Enrico
    Zilli, Marinella
    Tinari, Nicola
    Natoli, Clara
    Iacobelli, Stefano
    ANNALS OF ONCOLOGY, 2006, 17 : 97 - 97
  • [10] Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
    Mirzaei, Hamid Reza
    Rasekh, Parisa Sabet
    Nasrollahi, Fatemeh
    Rasekh, Parto Sabet
    Tirabad, Zahra Akbari
    RezaMoein, Hamid
    Pour, Taban Ghaffari
    Hajian, Parastoo
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
12345